Skip to main content
Journal cover image

Prostate cancer screening. Why the controversy?

Publication ,  Journal Article
Walther, PJ
Published in: Surg Oncol Clin N Am
April 1995

The development of new technologies has stimulated a crusade of screening for earlier detection of prostate cancer. This effort has resulted in controversy regarding its clinical use in this format. Until randomized clinical screening trials define the value of prostate cancer screening, clinicians who use screening approaches must gain a strong understanding of the natural history of the disease, the strengths and weaknesses of available screening methodologies, and epidemiologic considerations of prostate cancer risk.

Duke Scholars

Published In

Surg Oncol Clin N Am

ISSN

1055-3207

Publication Date

April 1995

Volume

4

Issue

2

Start / End Page

315 / 334

Location

United States

Related Subject Headings

  • SEER Program
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Oncology & Carcinogenesis
  • Middle Aged
  • Mass Screening
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Walther, P. J. (1995). Prostate cancer screening. Why the controversy? Surg Oncol Clin N Am, 4(2), 315–334.
Walther, P. J. “Prostate cancer screening. Why the controversy?Surg Oncol Clin N Am 4, no. 2 (April 1995): 315–34.
Walther PJ. Prostate cancer screening. Why the controversy? Surg Oncol Clin N Am. 1995 Apr;4(2):315–34.
Walther, P. J. “Prostate cancer screening. Why the controversy?Surg Oncol Clin N Am, vol. 4, no. 2, Apr. 1995, pp. 315–34.
Walther PJ. Prostate cancer screening. Why the controversy? Surg Oncol Clin N Am. 1995 Apr;4(2):315–334.
Journal cover image

Published In

Surg Oncol Clin N Am

ISSN

1055-3207

Publication Date

April 1995

Volume

4

Issue

2

Start / End Page

315 / 334

Location

United States

Related Subject Headings

  • SEER Program
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Oncology & Carcinogenesis
  • Middle Aged
  • Mass Screening
  • Male
  • Humans